French CRO Excelya inks deal with Veeva for data platform

Excelya has brought on Veeva Systems’ suite of clinical trial management tools for data cleaning and reporting in clinical trials.

The full-service French CRO inked the deal with the cloud software provider to speed database build cycles and reduce the downtime that can happened during midstudy design amendments, according to a Nov. 9 press release.

Financial terms of the contract weren’t disclosed.

"Effective data capture is key to running successful clinical trials," Paul MacDonald, Veeva’s senior director of strategy, said in the press release. “Excelya's addition of Veeva Vault EDC is an important step in transforming its approach to data management by simplifying study builds and trial execution for faster development of new medicines."

Veeva, which is based near San Francisco, has seen a string of companies recently opt for its services. In October, the company signed up 40 CROs and more than 120 clinical trial sites to use its suite of clinical trial management tools. Among the CROs signed were Labcorp, Parexel and Thermo Fisher’s PPD clinical trial division.

The company’s Vault platform was designed with metrics that allow CROs to improve the management of their study performances and increase transparency for sponsors. Vault also makes it easier for sponsors to collaborate and share information in real time.

Excelya, which has been growing its European operations, announced in July that three CROs had joined its group: Zeincro, The Clinical Company and Koehler eClinical.